PROGNOSTIC SIGNIFICANCE OF MINIMAL RESIDUAL DISEASE DETECTED BY MLL FUSION GENE TRANSCRIPTS IN INFANT ACUTE LYMPHOBLASTIC LEUKEMIA. UPDATED RESULTS OF 76 PATIENTS ENROLLED INTO MLL-BABY STUDY

被引：0
|
作者：
Tsaur, G. [1 ]
Popov, A. [2 ]
Riger, T. [1 ]
Solodovnikov, A. [1 ]
Kustanovich, A. [3 ]
Aleinikova, O. [3 ]
Olshanskaya, Y. [2 ]
Myakova, N. [2 ]
Verzhbitskaya, T. [1 ]
Shorikov, E. [4 ]
Streneva, O. [1 ]
Arakaev, O. [1 ]
Vlasova, A. [1 ]
Tsvirenko, S. [5 ]
Saveliev, L. [5 ]
Fechina, L. [1 ]
机构：
[1] Reg Children Hosp 1, Res Inst Med Cell Technol, Ekaterinburg, Russia
[2] Natl Res Inst Pediat Hematol Oncol & Immunol, Moscow, Russia
[3] Belarusian Res Ctr Pediat Oncol Hematol & Immunol, Minsk, BELARUS
[4] PET Technol, Ekaterinburg, Russia
[5] Ural State Med Univ, Ekaterinburg, Russia
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P161
引用
收藏
页码：30 / 30
页数：1
相关论文
共 50 条
  • [1] PROGNOSTIC SIGNIFICANCE OF FUSION GENE TRANSCRIPTS ASSESSMENT FOR MINIMAL RESIDUAL DISEASE MONITORING IN MLL-REARRANGED INFANT ACUTE LYMPHOBLASTIC LEUKEMIA WITHIN MLL-BABY TRIAL
    Tsaur, G.
    Popov, A.
    Nasedkina, T.
    Kustanovich, A.
    Kalennik, O.
    Aleinikova, O.
    Riger, T.
    Demina, A.
    Streneva, O.
    Solodovnikov, A.
    Shorikov, E.
    Saveliev, L.
    Fechina, L.
    HAEMATOLOGICA, 2012, 97 : 449 - 450
  • [2] Minimal Residual Disease Monitoring by Quantification of Fusion Gene Transcripts In Infant with MLL-rearranged Acute Lymphoblastic Leukemia Treated by MLL-Baby Protocol
    Tsaur, Grigory
    Popov, Alexander
    Nasedkina, Tatyana
    Kalennik, Olga
    Kustanovich, Anatoly
    Aleinikova, Olga
    Riger, Tatyana
    Yakovleva, Yulia
    Iyanova, Anna
    Shorikov, Egor
    Saveliev, Leonid
    Fechina, Larisa
    BLOOD, 2010, 116 (21) : 1126 - 1126
  • [3] PROGNOSTIC SIGNIFICANCE OF THE MINIMAL RESIDUAL DISEASE EVALUATED BY DETECTION OF MLL FUSION GENE TRANSCRIPTS IN INFANTS UNDER 1 YEAR OF AGE WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED BY THE MLL-BABY PROTOCOL
    Tsaur, G. A.
    Popov, A. M.
    Nasedkina, T. V.
    Kalennik, O. V.
    Kustanovich, A. M.
    Aleinikova, O. V.
    Solodovnikov, A. G.
    Riger, T. O.
    Streneva, O. V.
    Shorikov, E. V.
    Savelyev, L. I.
    Fechina, L. G.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2012, 57 (04): : 12 - 22
  • [4] PROGNOSTIC SIGNIFICANCE OF MLL FUSION GENE TRANSCRIPTS (FGT) MONITORING AS MARKER OF MINIMAL RESIDUAL DISEASE (MRD) IN INFANT ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
    Tsaur, Grigory
    Popov, Alexander
    Nasedkina, Tatyana
    Kalennik, Olga
    Kustanovich, Anatoly
    Aleinikova, Olga
    Riger, Tatyana
    Demina, Anna
    Streneva, Olga
    Solodovnikov, Alexander
    Shorikov, Egor
    Saveliev, Leonid
    Fechina, Larisa
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 1026 - 1026
  • [5] GENOMIC DNA BREAKPOINTS IN MLL GENE AND TREATMENT OUTCOME IN INFANTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA ENROLLED INTO MLL-BABY TRIAL
    Tsaur, G.
    Meyer, C.
    Popov, A.
    Kustanovich, A.
    Riger, T.
    Olshanskaya, Y.
    Matveeva, E.
    Fleischman, E.
    Sokova, O.
    Streneva, O.
    Saveliev, L.
    Marschalek, R.
    Solodovnikov, A.
    Shorikov, E.
    Fechina, L.
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S212 - S212
  • [6] Concordance and Prognostic Significance of Minimal Residual Disease Detection in Peripheral Blood and Bone Marrow Samples of Infants with MLL-rearranged Acute Lymphoblastic Leukemia Treated By MLL-Baby Protocol
    Tsaur, Grigory
    Popov, Alexander
    Riger, Tatyana
    Solodovnikov, Alexander
    Nasedkina, Tatyana
    Kustanovich, Anatoly
    Tsvirenko, Sergey
    Streneva, Olga
    Shorikov, Egor
    Saveliev, Leonid
    Fechina, Larisa
    BLOOD, 2014, 124 (21)
  • [7] COMPARISON OF BONE MARROW AND PERIPHERAL BLOOD SAMPLES FOR MINIMAL RESIDUAL DISEASE MONITORING IN INFANTS WITH MLL-REARRANGED ACUTE LYMPHOBLASTIC LEUKEMIA TREATED BY MLL-BABY PROTOCOL
    Tsaur, G.
    Popov, A.
    Riger, T.
    Solodovnikov, A.
    Nasedkina, T.
    Kustanovich, A.
    Aleinikova, O.
    Shorikov, E.
    Streneva, O.
    Saveliev, L.
    Fechina, L.
    HAEMATOLOGICA, 2014, 99 : 9 - 10
  • [8] Clinical outcome and monitoring of minimal residual disease in patients with acute lymphoblastic leukemia expressing the MLL/ENL fusion gene
    Elia, Loredana
    Grammatico, Sara
    Paoloni, Francesca
    Vignetti, Marco
    Rago, Angela
    Cenfra, Natalia
    Mecarocci, Sergio
    Mancini, Marco
    Luciani, Matteo
    Di Raimondo, Francesco
    Cazzaniga, Giovanni
    Matarazzo, Mabel
    Moleti, Maria Luisa
    Santoro, Lidia
    Gaidano, Gianluca
    Foa, Robin
    Mandelli, Franco
    Cimino, Giuseppe
    AMERICAN JOURNAL OF HEMATOLOGY, 2011, 86 (12) : 993 - 997
  • [9] Prognostic value of minimal residual disease measured by fusion-gene transcript in infants with KMT2A-rearranged acute lymphoblastic leukaemia treated according to the MLL-Baby protocol
    Tsaur, Grigory
    Popov, Alexander
    Riger, Tatiana
    Kustanovich, Anatoly
    Solodovnikov, Alexander
    Shorikov, Egor
    Demina, Anna
    Verzhbitskaya, Tatiana
    Streneva, Olga
    Makarova, Olga
    Lapotentova, Elena
    Aleinikova, Olga
    Miakova, Natalia
    Boichenko, Elmira
    Kondratchik, Konstantin
    Ponomareva, Natalia
    Karachunskiy, Alexander
    Roumiantsev, Alexander
    Fechina, Larisa
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (06) : 1151 - 1156
  • [10] Combination of chemotherapy and all-trans retinoic acid for the treatment KMT2A-rearranged infant acute lymphoblastic leukemia. Results of the MLL-Baby trial
    Larisa Fechina
    Alexander Popov
    Grigory Tsaur
    Guenter Henze
    Egor Shorikov
    Olga Makarova
    Olga Khlebnikova
    Yulia Zhukova
    Oleg Arakaev
    Olga Streneva
    Tatiana Verzhbitskaya
    Tatiana Riger
    Alexander Solodovnikov
    Elena Lapotentova
    Olga Aleinikova
    Natalia Myakova
    Elmira Boichenko
    Konstantin Kondratchik
    Olga Nikonova
    Alexander Shapochnik
    Marina Goroshkova
    Natalia Ponomareva
    Galina Novichkova
    Alexander Karachunskiy
    Alexander Roumiantsev
    Leukemia, 2023, 37 : 2276 - 2281
12345